
Brookside Capital
North America, California, United States, San Francisco
Description
They design, implement, and manage custom tailored portfolios of liquid assets for high net worth investors.
Investor Profile
Brookside Capital has made 45 investments, with 0 in the past 12 months and 22% as lead.
Stage Focus
- Series C (24%)
- Series D (18%)
- Series B (18%)
- Private Equity (9%)
- Series E (9%)
- Series Unknown (7%)
- Series F (4%)
- Post Ipo Equity (4%)
- Series A (4%)
- Series G (2%)
Country Focus
- United States (84%)
- China (9%)
- South Korea (2%)
- Singapore (2%)
- Indonesia (2%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Genetics
- Enterprise Software
- Biopharma
- Medical
- Video
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.